Articles published by SPR Therapeutics, Inc.
![](https://ml.globenewswire.com/media/29e14cfb-141a-44c9-b655-b478243b5765/small/spr-logo-png.png)
![](https://ml.globenewswire.com/media/29e14cfb-141a-44c9-b655-b478243b5765/small/spr-logo-png.png)
![](https://ml.globenewswire.com/media/29e14cfb-141a-44c9-b655-b478243b5765/small/spr-logo-png.png)
![](https://ml.globenewswire.com/media/29e14cfb-141a-44c9-b655-b478243b5765/small/spr-logo-png.png)
![](https://ml.globenewswire.com/media/29e14cfb-141a-44c9-b655-b478243b5765/small/spr-logo-png.png)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
New SPR Therapeutics Data Presented at ASRA Pain Medicine Meeting 2023
November 13, 2023
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
Via GlobeNewswire
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
![](https://ml.globenewswire.com/media/9cf05877-6c2a-4d66-869c-830b57768722/small/spr-therapeutics-logo-361-tm-jpg.jpg)
SPR Therapeutics Debuts Occipital Nerve Stimulation Data at ASRA 2022
November 17, 2022
Via GlobeNewswire
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.